Learn about AFCR’s support for the development and conversion of exciting laboratory breakthroughs into new and more effective cancer treatments, screenings and preventive technologies. Listed in this section are Translational Research initiatives which are or have been sponsored by AFCR, made possible with our dedicated donors’ support.
Building Safer, More Effective CAR-T Cell Therapies for Cancer Patients
CAR-T Cell Therapies are Not Working Against Solid Cancers Doctors divide cancer into two main types: solid tumor cancers and cancers in the blood. Solid cancer is an abnormal mass…
Revolutionary Drug Delivery Platform: Improves Effectiveness and Tolerability of Cancer Treatments
THE CHALLENGE——Patient Circumstances Limit Potential Viable Therapies Patients afflicted with tumors and cancers are in need of urgent, active intervention in order to have the best possibilities for treatment success…
Engaging the Immune System to Treat Gastrointestinal Cancers
THE CHALLENGE ——High Incidence and Mortality, Few Viable and Dedicated Drugs Gastrointestinal (GI) cancers including colorectal, stomach, liver, esophageal, and pancreas have high incidence and mortality. Globally, they have the…
Multi-functional antibodies to target cancer on multiple fronts
Advanced cancers typically suppress the immune response by multiple mechanisms. By carefully engineering multi-functional antibody therapies, there is the potential for more effective treatment.
Determining the Risk of Hereditary Breast and Ovarian Cancer (HBOC) in China
Understanding the risk of breast cancer in the Chinese population is very important due to the exponential increase in incidence...
Gastric Cancer Research
Gastric cancer is the fourth most common cancer and the second leading cause of cancer death worldwide.
